VANCOUVER, BC –(Marketwired – March 22, 2016) – Moseda Technologies Inc. (TSX VENTURE: opens in a new windowMSD) (“Moseda” or the “Company“), a technology company focused on developing innovative mobile health (mHealth) and telemedicine solutions for Community-Based Healthcare, is pleased to announce that it has secured a pilot with The Feldman Institute in Baton Rouge, LA, USA. The pilot will evaluate the use of Moseda’s CareKit Health platform with patients who have been discharged home after interventional pain management surgery or have returned to their homes between treatments at The Feldman Institute.
“We are excited to be piloting Moseda’s newest product, the CareKit Health platform, with The Feldman Institute” said Dr. Lisa Crossley, CEO of Moseda. “The CareKit platform uses mobile applications and wearable technology to make high quality care accessible and economical for patients in their own homes. We look forward to working with The Feldman Institute to improve treatment outcomes, reduce the risk of post-surgical complications and increase access to specialized pain management care for their chronic pain patients at home.”
“One of our key goals at The Feldman Institute is to provide our patients with compassionate, accessible healthcare.” said Dr. Arnold E. Feldman, Medical Director at The Feldman Institute and First Choice Surgery Center. “Our pilot with Moseda is designed to validate the use of a novel technology solution that will help our patients better manage and document their symptoms in the home, as well as facilitating secure and timely communication between patients and family members and their care team at The Feldman Institute”.
The Feldman Institute’s mission is to relieve chronic pain and restore health, comfort and quality of life in a collaborative and compassionate environment. The Feldman Institute is committed to eliminating pain through research and innovation while working closely with each patient to find their appropriate level of care. The Feldman Institute is dedicated to helping its patients through a comprehensive program of interventional pain management. The diagnosis and treatment techniques offered at the Feldman Institute represent the leading edge of recent medical advances.
ON BEHALF OF THE BOARD
“Dr. Lisa Crossley”
CEO and Director
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Cautionary Statements Regarding Forward Looking Information
Certain statements in this press release constitute forward-looking statements, within the meaning of applicable securities laws. All statements that are not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance, are “forward-looking statements”.
We caution you that such “forward-looking statements” involve known and unknown risks and uncertainties that could cause actual and future events to differ materially from those anticipated in such statements.
Forward-looking statements include, but are not limited to, statements with respect to commercial operations, including technology development, anticipated revenues, projected size of market, and other information that is based on forecasts of future results, estimates of amounts not yet determinable and assumptions of management.
Moseda Technologies Inc. (the “Company“) does not intend, and does not assume any obligation, to update these forward-looking statements except as required by law. These forward-looking statements involve risks and uncertainties relating to, among other things, technology development and marketing activities, the Company’s historical experience with technology development, uninsured risks. Actual results may differ materially from those expressed or implied by such forward-looking statements.